Published in Tex Heart Inst J on October 01, 2014
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med (2002) 12.84
Universal definition of myocardial infarction. J Am Coll Cardiol (2007) 8.68
Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med (2001) 6.38
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med (2007) 5.37
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med (2007) 4.95
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet (2003) 4.68
Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol (2001) 4.50
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation (2004) 3.23
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol (2005) 3.17
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med (2007) 2.91
Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA (2007) 2.43
Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial. J Am Coll Cardiol (2005) 1.87
The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol (2005) 1.21
Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention (2005) 1.00
Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J (2007) 0.88
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial. EuroIntervention (2006) 0.87
Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention. EuroIntervention (2011) 0.85
Percutaneous treatment of multivessel coronary disease in the drug eluting stent era: comparison of bare-metal stents, drug-eluting stents and a mixed approach in a large multicentre registry. EuroIntervention (2007) 0.82
Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry. J Am Coll Cardiol (2006) 0.82
Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation. EuroIntervention (2010) 0.81
The association of opium with coronary artery disease. Eur J Cardiovasc Prev Rehabil (2007) 1.75
Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clin Res Cardiol (2011) 1.52
Success rate, procedural complications and clinical outcomes of coronary interventions in octogenarians: a case-control study. J Tehran Heart Cent (2011) 1.47
The impact of cytochrome P450 2C19 polymorphism on the occurrence of one-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study. Anatol J Cardiol (2015) 1.42
Non-total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide in hematopoietic stem cell transplantation for malignant infantile osteopetrosis. Pediatr Transplant (2015) 1.39
Effects of N-acetylcysteine on the cardiac remodeling biomarkers and major adverse events following acute myocardial infarction: a randomized clinical trial. Am J Cardiovasc Drugs (2014) 1.37
Opium consumption in men and diabetes mellitus in women are the most important risk factors of premature coronary artery disease in Iran. Int J Cardiol (2009) 1.21
Stent-graft exclusion of multiple symptomatic coronary artery fistulae. Tex Heart Inst J (2007) 1.18
Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial. Am J Kidney Dis (2009) 1.12
Clinical outcomes of drug-eluting stents compared with bare metal stents in our routine clinical practice. Hellenic J Cardiol (2008) 1.05
Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting. Cardiovasc Diabetol (2012) 1.04
Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc Disord (2006) 1.02
Correlation between ABO blood groups, major risk factors, and coronary artery disease. Int J Cardiol (2005) 1.01
Evaluation of subclinical left ventricular dysfunction in diabetic patients: longitudinal strain velocities and left ventricular dyssynchrony by two-dimensional speckle tracking echocardiography study. Echocardiography (2013) 0.97
Stem cell transplantation; Iranian experience. Arch Iran Med (2009) 0.95
Tricuspid regurgitation improvement in relation to the amount of pulmonary artery pressure reduction. J Tehran Heart Cent (2010) 0.94
Adverse drug reactions induced by cardiovascular drugs in cardiovascular care unit patients. Pharmacoepidemiol Drug Saf (2010) 0.93
Transcatheter closure of a coronary fistula with an Amplatzer vascular plug: should a retrograde approach be standard? Tex Heart Inst J (2008) 0.93
Self-expanding nitinol stent implantation for treatment of aortic coarctation. J Endovasc Ther (2009) 0.92
Outcomes of primary percutaneous coronary intervention in acute myocardial infarction at Tehran Heart Center. Med Princ Pract (2007) 0.88
Asymptomatic bacteriuria in type 2 Iranian diabetic women: a cross sectional study. BMC Womens Health (2006) 0.87
Comparison of outcomes of percutaneous coronary intervention on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: a cross-sectional study. BMC Cardiovasc Disord (2007) 0.87
The association between coronary arterial dominancy and extent of coronary artery disease in angiography and paraclinical studies. Clin Anat (2008) 0.87
Demographics and Angiographic Findings in Patients under 35 Years of Age with Acute ST Elevation Myocardial Infarction. J Tehran Heart Cent (2011) 0.87
Sodium bicarbonate in preventing contrast nephropathy in patients at risk for volume overload: a randomized controlled trial. J Nephrol (2010) 0.86
Aortic and mitral valve atherosclerosis: Predictive factors and associations with coronary atherosclerosis using Gensini score. Arch Med Res (2009) 0.84
Percutaneous coronary intervention to treat chronic total occlusion: predictors of technical success and one-year clinical outcome. Tex Heart Inst J (2014) 0.84
Hematopoietic stem cell transplantation in Iran: 1991 to 2008. Hematol Oncol Stem Cell Ther (2010) 0.84
Risk factors for major complications due to delay in surgery in staged carotid stenting and coronary bypass graft surgery. EuroIntervention (2007) 0.83
Association between preprocedural hemoglobin level and 1-year outcome of elective percutaneous coronary intervention. J Cardiovasc Med (Hagerstown) (2014) 0.83
KIR2DS3 is associated with protection against acute myeloid leukemia. Iran J Immunol (2010) 0.83
One-year clinical outcomes of ultra long apollo polymer-based Paclitaxel-eluting stents in patients with complex, long coronary artery lesions. J Tehran Heart Cent (2011) 0.82
The outcome of allogeneic hematopoietic stem cell transplants without total body irradiation in pediatric patients with acute lymphoblastic leukemia: single centre experience. J Pediatr Hematol Oncol (2012) 0.82
The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation. Leuk Res (2013) 0.81
Percutaneous transvenous mitral commissurotomy: significance of echocardiographic assessment in prediction of immediate result. Arch Iran Med (2012) 0.81
Clinical characteristics and risk assessment of ST-segment elevation myocardial infarction patients of an Iranian referral center. J Cardiovasc Med (Hagerstown) (2012) 0.81
Factors predicting discontinuation of a hospital-based cardiac rehabilitation programme. Kardiol Pol (2009) 0.81
Non-TBI hematopoietic stem cell transplantation in pediatric AML patients: a single-center experience. J Pediatr Hematol Oncol (2013) 0.80
Measurement of Atrial Septal Defect Size: A Comparative Study between Transesophageal Echocardiography and Balloon Occlusive Diameter Method. J Tehran Heart Cent (2010) 0.80
Staged carotid artery stenting and coronary artery bypass surgery versus isolated coronary artery bypass surgery in concomitant coronary and carotid disease. J Invasive Cardiol (2013) 0.80
Cholesteryl ester transfer protein gene polymorphism (I405V) and premature coronary artery disease in an Iranian population. Bosn J Basic Med Sci (2016) 0.79
A novel scoring system for identifying high-risk patients undergoing carotid stenting. Arch Iran Med (2006) 0.79
Comparison of hypertonic saline versus normal saline on cytokine profile during CABG. Daru (2012) 0.79
In-hospital and mid-term clinical outcomes after percutaneous coronary intervention with the use of sirolimus- or paclitaxel-eluting stents. Kardiol Pol (2009) 0.79
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents. J Tehran Heart Cent (2013) 0.78
Sex-related changes in tissue Doppler imaging parameters among patients with acute pulmonary thromboembolism. J Ultrasound Med (2013) 0.78
In-hospital and late clinical outcomes of direct stenting strategy versus stenting after predilatation for the treatment of coronary artery lesions. Indian Heart J (2009) 0.78
On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes. Tex Heart Inst J (2012) 0.78
Cytokine gene polymorphisms in common variable immunodeficiency. Int Arch Allergy Immunol (2009) 0.78
Coronary arteries bypass grafting surgery in elderly patients. J Tehran Heart Cent (2013) 0.78
Amelioration of cardio-respiratory perturbations following Mesobuthus eupeus envenomation in anesthetized rabbits with commercial polyvalent F(ab')2 antivenom. Toxicon (2011) 0.77
Long-term results of non-fludarabine versus fludarabine-based stem cell transplantation without total body irradiation in Fanconi anemia patients. Hematol Oncol Stem Cell Ther (2011) 0.77
Novel approach to reduce postsurgical adhesions to a minimum: administration of losartan plus atorvastatin intraperitoneally. J Surg Res (2012) 0.77
Frequency and predictors of renal artery stenosis in patients undergoing simultaneous coronary and renal catheterization. J Tehran Heart Cent (2012) 0.77
Evaluating the Effect of Intracoronary N-Acetylcysteine on Platelet Activation Markers After Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction. Am J Ther (2016) 0.76
Comparison of cardiovascular risk factors and biochemical profile in patients with cardiac syndrome X and obstructive coronary artery disease: A propensity score-matched study. ARYA Atheroscler (2013) 0.76
Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation. J Tehran Heart Cent (2012) 0.76
Hematopoietic stem cell transplantation in acute promyelocytic leukemia, experience in Iran. Arch Iran Med (2011) 0.76